Russian Covid-19 vaccine will be up for global scrutiny, say experts

Reports say the country's Sechenov University has successfully completed human trials of its vaccine candidate for the novel coronavirus

Russia's Sechenov University has successfully completed human trials of its vaccine candidate for the novel coronavirus, according to reports. Experts say that the global scientific community would now vet the efficacy of the vaccine before it can be used by countries across the world. Even if all goes well, it is still sometime away before it can be distributed globally. 

Russian news agency Sputnik said that Vadim Tarasov, the Director of the Institute for Translational Medicine and Biotechnology, told the agency that the university has completed the trial of the vaccine developed by the Gamaleya Institute, an epidemiology research centre in